Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rigel Suzuki

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
The Journal of General Virology|March 20, 2025
NEDD4-binding protein 1 suppresses hepatitis B virus replication by regulating viral RNAsNobuhiro Kobayashi, Saori Suzuki, Yuki Sakamoto, et al.
Cell Reports. Medicine|August 16, 2023
Safety and immunogenicity of SARS-CoV-2 self-amplifying RNA vaccine expressing an anchored RBD: A randomized, observer-blind phase 1 studyWataru Akahata, Takashi Sekida, Takuto Nogimori, et al.
Lab on a Chip|October 25, 2023
High-precision rapid testing of omicron SARS-CoV-2 variants in clinical samples using AI-nanoporeKaoru Murakami, Shimpei I Kubota, Kumiko Tanaka, et al.
Nature|February 1, 2022
Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variantRigel Suzuki, Daichi Yamasoba, Izumi Kimura, et al.
Nature|May 29, 2026
Author Correction: Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variantRigel Suzuki, Daichi Yamasoba, Izumi Kimura, et al.
Communications Biology|July 24, 2023
Comparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5Tomokazu Tamura, Daichi Yamasoba, Yoshitaka Oda, et al.
Journal of Virology|October 5, 2023
Multiple mutations of SARS-CoV-2 Omicron BA.2 variant orchestrate its virological characteristicsIzumi Kimura, Daichi Yamasoba, Hesham Nasser, et al.
Cell Host & Microbe|January 27, 2024
Virological characteristics of the SARS-CoV-2 BA.2.86 variantTomokazu Tamura, Keita Mizuma, Hesham Nasser, et al.
Nature Communications|February 8, 2024
Virological characteristics of the SARS-CoV-2 Omicron XBB.1.5 variantTomokazu Tamura, Takashi Irie, Sayaka Deguchi, et al.
Nature Communications|May 11, 2023
Convergent evolution of SARS-CoV-2 Omicron subvariants leading to the emergence of BQ.1.1 variantJumpei Ito, Rigel Suzuki, Keiya Uriu, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
The Journal of General Virology|March 20, 2025
NEDD4-binding protein 1 suppresses hepatitis B virus replication by regulating viral RNAsNobuhiro Kobayashi, Saori Suzuki, Yuki Sakamoto, et al.
Cell Reports. Medicine|August 16, 2023
Safety and immunogenicity of SARS-CoV-2 self-amplifying RNA vaccine expressing an anchored RBD: A randomized, observer-blind phase 1 studyWataru Akahata, Takashi Sekida, Takuto Nogimori, et al.
Lab on a Chip|October 25, 2023
High-precision rapid testing of omicron SARS-CoV-2 variants in clinical samples using AI-nanoporeKaoru Murakami, Shimpei I Kubota, Kumiko Tanaka, et al.
Nature|February 1, 2022
Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variantRigel Suzuki, Daichi Yamasoba, Izumi Kimura, et al.
Nature|May 29, 2026
Author Correction: Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variantRigel Suzuki, Daichi Yamasoba, Izumi Kimura, et al.
Communications Biology|July 24, 2023
Comparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5Tomokazu Tamura, Daichi Yamasoba, Yoshitaka Oda, et al.
Journal of Virology|October 5, 2023
Multiple mutations of SARS-CoV-2 Omicron BA.2 variant orchestrate its virological characteristicsIzumi Kimura, Daichi Yamasoba, Hesham Nasser, et al.
Cell Host & Microbe|January 27, 2024
Virological characteristics of the SARS-CoV-2 BA.2.86 variantTomokazu Tamura, Keita Mizuma, Hesham Nasser, et al.
Nature Communications|February 8, 2024
Virological characteristics of the SARS-CoV-2 Omicron XBB.1.5 variantTomokazu Tamura, Takashi Irie, Sayaka Deguchi, et al.
Nature Communications|May 11, 2023
Convergent evolution of SARS-CoV-2 Omicron subvariants leading to the emergence of BQ.1.1 variantJumpei Ito, Rigel Suzuki, Keiya Uriu, et al.
Pageof 5